Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000532:radiotherapy; D002470:Cell Survival / Q000528:radiation effects; D003857:Deoxyuridine / Q000378:metabolism; D005260:Female; D006979:Hyperthermia, Induced; D000860:Hypoxia; D007939:Leukemia L1210 / Q000188:drug therapy / Q000532:radiotherapy; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D011836:Radiation Tolerance; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy / Q000532:radiotherapy
D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D008795:Metronidazole; D003857:Deoxyuridine